| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |